148 related articles for article (PubMed ID: 30448761)
21. HCN Channel as Therapeutic Targets for Heart Failure and Pain.
Cao Y; Pang J; Zhou P
Curr Top Med Chem; 2016; 16(16):1855-61. PubMed ID: 26667117
[TBL] [Abstract][Full Text] [Related]
22. Validation of the binding stoichiometry between HCN channels and their neuronal regulator TRIP8b by single molecule measurements.
Saponaro A; Vallese F; Porro A; Clarke OB
Front Physiol; 2022; 13():998176. PubMed ID: 36225302
[TBL] [Abstract][Full Text] [Related]
23. Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.
Weerasinghe D; Menon P; Vucic S
J Neurophysiol; 2017 Dec; 118(6):3044-3050. PubMed ID: 28904107
[TBL] [Abstract][Full Text] [Related]
24. Structural mechanism for the regulation of HCN ion channels by the accessory protein TRIP8b.
DeBerg HA; Bankston JR; Rosenbaum JC; Brzovic PS; Zagotta WN; Stoll S
Structure; 2015 Apr; 23(4):734-44. PubMed ID: 25800552
[TBL] [Abstract][Full Text] [Related]
25. Nucleus accumbens hyperpolarization-activated cyclic nucleotide-gated channels modulate methamphetamine self-administration in rats.
Cao DN; Song R; Zhang SZ; Wu N; Li J
Psychopharmacology (Berl); 2016 Aug; 233(15-16):3017-29. PubMed ID: 27329413
[TBL] [Abstract][Full Text] [Related]
26. HCN Channels Modulators: The Need for Selectivity.
Novella Romanelli M; Sartiani L; Masi A; Mannaioni G; Manetti D; Mugelli A; Cerbai E
Curr Top Med Chem; 2016; 16(16):1764-91. PubMed ID: 26975509
[TBL] [Abstract][Full Text] [Related]
27. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
[TBL] [Abstract][Full Text] [Related]
28. A synthetic peptide that prevents cAMP regulation in mammalian hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
Saponaro A; Cantini F; Porro A; Bucchi A; DiFrancesco D; Maione V; Donadoni C; Introini B; Mesirca P; Mangoni ME; Thiel G; Banci L; Santoro B; Moroni A
Elife; 2018 Jun; 7():. PubMed ID: 29923826
[TBL] [Abstract][Full Text] [Related]
29. Alpha 2 adrenoceptor agonist guanabenz directly inhibits hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels in mesencephalic trigeminal nucleus neurons.
Won J; Lee PR; Oh SB
Eur J Pharmacol; 2019 Jul; 854():320-327. PubMed ID: 31009638
[TBL] [Abstract][Full Text] [Related]
30. Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels.
Gamo NJ; Lur G; Higley MJ; Wang M; Paspalas CD; Vijayraghavan S; Yang Y; Ramos BP; Peng K; Kata A; Boven L; Lin F; Roman L; Lee D; Arnsten AF
Biol Psychiatry; 2015 Dec; 78(12):860-70. PubMed ID: 25731884
[TBL] [Abstract][Full Text] [Related]
31. Faster, better, stronger: towards new antidepressant therapeutic strategies.
O'Leary OF; Dinan TG; Cryan JF
Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
[TBL] [Abstract][Full Text] [Related]
32. HCN channel antagonist ZD7288 ameliorates neuropathic pain and associated depression.
Yang L; Liu X; Yao K; Sun Y; Jiang F; Yan H; Mao P; Fan S; Wei X; Liu Y; Yuan W; Zhang S
Brain Res; 2019 Aug; 1717():204-213. PubMed ID: 30940440
[TBL] [Abstract][Full Text] [Related]
33. HCN channels in the hippocampus regulate active coping behavior.
Fisher DW; Han Y; Lyman KA; Heuermann RJ; Bean LA; Ybarra N; Foote KM; Dong H; Nicholson DA; Chetkovich DM
J Neurochem; 2018 Sep; 146(6):753-766. PubMed ID: 29953635
[TBL] [Abstract][Full Text] [Related]
34. Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
Sartiani L; Romanelli MN; Mugelli A; Cerbai E
Curr Drug Targets; 2015; 16(8):868-76. PubMed ID: 26028050
[TBL] [Abstract][Full Text] [Related]
35. The impact of hyperpolarization-activated cyclic nucleotide-gated (HCN) and voltage-gated potassium KCNQ/Kv7 channels on primary microglia function.
Vay SU; Flitsch LJ; Rabenstein M; Monière H; Jakovcevski I; Andjus P; Bijelic D; Blaschke S; Walter HL; Fink GR; Schroeter M; Rueger MA
J Neuroinflammation; 2020 Apr; 17(1):100. PubMed ID: 32248813
[TBL] [Abstract][Full Text] [Related]
36. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
Quesseveur G; Gardier AM; Guiard BP
Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
[TBL] [Abstract][Full Text] [Related]
37. Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation.
Zolles G; Wenzel D; Bildl W; Schulte U; Hofmann A; Müller CS; Thumfart JO; Vlachos A; Deller T; Pfeifer A; Fleischmann BK; Roeper J; Fakler B; Klöcker N
Neuron; 2009 Jun; 62(6):814-25. PubMed ID: 19555650
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Kv1.2-mediated outward current in TRIP8b-deficient mice.
Labbaf A; Dellin M; Komadowski M; Chetkovich DM; Decher N; Pape HC; Seebohm G; Budde T; Zobeiri M
Biol Chem; 2023 Mar; 404(4):291-302. PubMed ID: 36852869
[TBL] [Abstract][Full Text] [Related]
39. Peripheral hyperpolarization-activated cyclic nucleotide-gated channels contribute to inflammation-induced hypersensitivity of the rat temporomandibular joint.
Hatch RJ; Jennings EA; Ivanusic JJ
Eur J Pain; 2013 Aug; 17(7):972-82. PubMed ID: 23255289
[TBL] [Abstract][Full Text] [Related]
40. Beyond serotonin: newer antidepressants in the future.
Rakesh G; Pae CU; Masand PS
Expert Rev Neurother; 2017 Aug; 17(8):777-790. PubMed ID: 28598698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
